Retail investors are getting cold feet about stocks, just when the market needs them most
Last week’s carnage for hedge funds highlighted the relative decline in trading activity among retail investors.
Wine and Stocks Thoughts about wine and stocks
The stock market’s biggest test in weeks is here
Here’s what’s I’m watching this morning: A week chockablock with enough catalysts that we might finally get some answers about the direction of the market by the end of it.
Worried about this stock-market selloff? Relief may be coming after the midterms — no matter who wins.
The nine months between Election Day and June 30 have seen the S&P 500 deliver an average return of 15.5% going back to 1950.
‘Nonanswers’ aren’t working. This is what investors really need from the Fed.
What really matters to investors, economists say, is for Fed Chairman Kevin Warsh to prove he can successfully communicate the central bank’s strategy.
My niece’s college rent is covered by a 529 plan. What else can I pay for tax-free?
“We worked out a monthly budget of $1,500 for her share of rent, utilities and food, including groceries and meals on campus.”
My spouse was awarded $90,000 from my 401(k) in our divorce. How is that fair?
“I retired in 2020 and subsequently went through a divorce a few years later.”
We have a $300,000 mortgage with a 2.75% interest rate. I want to pay it off. My husband says I’m crazy. Who’s right?
“I don’t want to enter retirement owing six figures when we have the cash to clear it.”
My father-in-law, 81, sold his $75,000 home to pay his daughter’s $50,000 debt. How can I keep him from becoming destitute?
“Nothing has been set aside for his needs.”
Oil is now flowing out of the Persian Gulf like before the Iran war. Why prices may still not come down anytime soon.
Oil flows out of the Persian Gulf in October nearly returned to levels seen before the start of the Iran war, but traders remain wary about a fragile recovery.
Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.
